27822855|t|High-Throughput Genotyping with TaqMan Allelic Discrimination and Allele-Specific Genotyping Assays
27822855|a|Real-time PCR -based genotyping methods, such as TaqMan allelic discrimination assays and allele-specific genotyping, are particularly useful when screening a handful of single nucleotide polymorphisms in hundreds of samples; either derived from different individuals, tissues, or pre - amplified DNA. Although real-time PCR - based methods such as TaqMan are well-established, alternative methods, like allele-specific genotyping, are powerful alternatives, especially for genotyping short tandem repeat (STR) length polymorphisms. Here, we describe all relevant aspects when developing an assay for a new SNP or STR using either TaqMan or allele-specific genotyping, respectively, such as primer and probe design, optimization of reaction conditions, the experimental procedure for typing hundreds of samples, and finally the data evaluation. Our goal is to provide a guideline for developing genotyping assays using these two approaches that render reliable and reproducible genotype calls involving minimal optimization.
27822855	16	26	Genotyping	T059,T063	C3178894
27822855	32	61	TaqMan Allelic Discrimination	T059,T063	C3178894
27822855	66	99	Allele-Specific Genotyping Assays	T059,T063	C3178894
27822855	100	113	Real-time PCR	T063	C1709846
27822855	121	139	genotyping methods	T059,T063	C3178894
27822855	149	185	TaqMan allelic discrimination assays	T059,T063	C3178894
27822855	190	216	allele-specific genotyping	T059,T063	C3178894
27822855	235	241	useful	T080	C3827682
27822855	247	256	screening	T060	C0813145
27822855	270	301	single nucleotide polymorphisms	T086	C0752046
27822855	317	324	samples	T167	C0370003
27822855	346	355	different	T080	C1705242
27822855	356	367	individuals	T098	C0027361
27822855	369	376	tissues	T024	C0040300
27822855	381	384	pre	T079	C0332152
27822855	387	400	amplified DNA	T045	C0683230
27822855	411	424	real-time PCR	T063	C1709846
27822855	427	432	based	T169	C1527178
27822855	433	440	methods	T170	C0025663
27822855	449	455	TaqMan	T059,T063	C3178894
27822855	460	476	well-established	T080	C0443211
27822855	478	489	alternative	T077	C1523987
27822855	490	497	methods	T170	C0025663
27822855	504	530	allele-specific genotyping	T059,T063	C3178894
27822855	545	557	alternatives	T077	C1523987
27822855	574	584	genotyping	T059,T063	C3178894
27822855	585	604	short tandem repeat	T114,T123	C1519302
27822855	605	610	(STR)	T114,T123	C1519302
27822855	611	617	length	T081	C1444754
27822855	618	631	polymorphisms	T045	C0032529
27822855	655	663	relevant	T080	C2347946
27822855	664	671	aspects	T080	C1521970
27822855	677	687	developing	T169	C1527148
27822855	691	696	assay	T059	C1510438
27822855	707	710	SNP	T086	C0752046
27822855	714	717	STR	T114,T123	C1519302
27822855	731	737	TaqMan	T059,T063	C3178894
27822855	741	767	allele-specific genotyping	T059,T063	C3178894
27822855	791	797	primer	T114	C0206416
27822855	802	807	probe	T114,T130	C0012893
27822855	816	828	optimization	T052	C2698650
27822855	832	840	reaction	T169	C0443286
27822855	841	851	conditions	T080	C0348080
27822855	857	890	experimental procedure for typing	T059,T063	C3178894
27822855	903	910	samples	T167	C0370003
27822855	928	932	data	T078	C1511726
27822855	933	943	evaluation	T058	C0220825
27822855	949	953	goal	T170	C0018017
27822855	960	967	provide	T052	C1999230
27822855	970	979	guideline	T170	C0162791
27822855	984	994	developing	T169	C1527148
27822855	995	1012	genotyping assays	T059,T063	C3178894
27822855	1029	1039	approaches	T169	C1292724
27822855	1065	1077	reproducible	T080	C1514863
27822855	1078	1092	genotype calls	T059,T063	C3178894
27822855	1093	1102	involving	T169	C1314939
27822855	1103	1110	minimal	T080	C0547040
27822855	1111	1123	optimization	T052	C2698650